In recent years, several studies have demonstrated that BRD4 plays a key role in cell proliferation, survival and metastasis of breast cancer, and can be used as an emerging therapeutic target for down-regulating TNBC [4–6]. The gene discussed is BRD4; the disease is breast carcinoma.